Welcome to OpenHands (formerly OpenDevin), a platform for software development agents powered by AI. OpenHands agents can do anything a human developer can: modify code, run commands, browse the web, ...
Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to ...
Denmark has banned all civilian drone flights this week ahead of a European Union summit in Copenhagen, the country's transport minister said on Sunday. The ministry said the decision was made in ...
When consumed in moderation, beef can improve muscle growth and maintenance. But high consumption of beef has been linked to an increased risk for heart disease and cancer. Beef is the meat of cattle ...
FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment ...
JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key ...
The oral GLP-2 tablet program combines a proprietary long acting GLP-2 agonist developed by OPKO with Entera’s proprietary N-Tab™ technology for patients suffering from short bowel syndrome and ...
Margaret Rouse is an award-winning technical writer and teacher known for her ability to explain complex technical subjects simply to a non-technical, business audience. Over… Group step-by-step ...
The Grand Final of the Eurovision Song Contest 2025 took place in St. Jakobshalle, Basel, on Saturday 17 May with Semi-Finals on Tuesday 13 and Thursday 15 May, after it was selected by Host ...
Ocean services provider DeepOcean, with its joint venture partners Solstad Offshore and Østensjø Rederi, has taken delivery of a newbuild uncrewed surface vessel (USV), which will be used for subsea ...
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback